J. F. Dufour, C. M. Oneta, J. J. Gonvers, F. Bihl, A. Cerny, J. M. Cereda, J. F. Zala, B. Helbling, M. Steuerwald and A. Zimmermann, “Randomized Placebo-Controlled Trial of Ursodeoxycholic Acid with Vitamin E in Nonalcoholic Steatohepatitis,” Clinical Gastroenterology and Hepatology, Vol. 4, No. 12, 2006, pp. 1537-1543.
http://dx.doi.org/10.1016/j.cgh.2006.09.025

has been cited by the following article:

• TITLE: Vitamin E Therapy in Non-Alcoholic Fatty Liver Disease

  AUTHORS: Xiangbing Shu, Li Zhang, Guang Ji

  KEYWORDS: Vitamin E; Nonalcoholic Fatty Liver; Therapy

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.5 No.3, January 24, 2014

  ABSTRACT: Non-alcoholic fatty liver disease (NAFLD) is closely related to oxidative stress. Vitamin E (VE) is an effective antioxidant, which could relieve NAFLD symptoms by improving the balance of oxidation and anti-oxidation. However, recent researches indicate that the functional mechanisms of VE are not only limited to anti-oxidation, but also include adjusting the metabolism disorders of glucose and lipid. Furthermore, the efficacy of VE remains controversial in the treatment of NAFLD by far, and the suitable condition of patient, drug dosage, drug safety and course of treatment during clinical application still need to be discussed. Therefore, this paper reviewed the recent study progresses of clinical application of VE alone and VE and other drugs.